Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission

Journal of Physiology

Volumn 593, Issue 4, 2015, Pages 871-886

  Kim, Jimok ^a   Li, Yong ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 2 RECEPTOR; GLUTAMIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; BORNANE DERIVATIVE; PYRAZOLE DERIVATIVE;

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN SLICE; CONTROLLED STUDY; DENDRITIC SPINE; EXCITATORY POSTSYNAPTIC POTENTIAL; FREQUENCY MODULATION; HIPPOCAMPUS; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; FEMALE; GENETICS; KNOCKOUT MOUSE; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BORNANES; EXCITATORY POSTSYNAPTIC POTENTIALS; FEMALE; HIPPOCAMPUS; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; PYRAZOLES; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB2; SYNAPTIC TRANSMISSION;

EID: 84923411240     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2014.286633     Document Type: Article

References (71)

1. Alger BE (2002). Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog Neurobiol 68, 247-286.
2. Alonso M, Medina JH & Pozzo-Miller L (2004). ERK1/2 activation is necessary for BDNF to increase dendritic spine density in hippocampal CA1 pyramidal neurons. Learn Mem 11, 172-178.
3. 2 receptors and the endocannabinoid system for the treatment of pain. Brain Res Rev 60, 255-266.
4. 2 receptors in the mouse hippocampus. Neurochem Int 60, 145-152.
5. Aouadi M, Binetruy B, Caron L, Le Marchand-Brustel Y & Bost F (2006). Role of MAPKs in development and differentiation: lessons from knockout mice. Biochimie 88, 1091-1098.
6. 2 receptors. Neuropsychopharmacology 37, 1749-1763.
7. 2: a cannabinoid receptor with an identity crisis. Br J Pharmacol 160, 467-479.
8. Bosch M & Hayashi Y (2012). Structural plasticity of dendritic spines. Curr Opin Neurobiol 22, 383-388.
9. Bourne J & Harris KM (2007). Do thin spines learn to be mushroom spines that remember? Curr Opin Neurobiol 17, 381-386.
10. Brusco A, Tagliaferro P, Saez T & Onaivi ES (2008). Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus. Synapse 62, 944-949.
11. Burrone J, O'Byrne M & Murthy VN (2002). Multiple forms of synaptic plasticity triggered by selective suppression of activity in individual neurons. Nature 420, 414-418.
12. Busquets-Garcia A, Puighermanal E, Pastor A, de la Torre R, Maldonado R & Ozaita A (2011). Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses. Biol Psychiatry 70, 479-486.
13. Castillo PE, Younts TJ, Chávez AE & Hashimotodani Y (2012). Endocannabinoid signaling and synaptic function. Neuron 76, 70-81.
14. 9-THC-caused synaptic and memory impairments are mediated through COX-2 signaling. Cell 155, 1154-1165.
15. Chevaleyre V, Takahashi KA & Castillo PE (2006). Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci 29, 37-76.
16. Demuth DG & Molleman A (2006). Cannabinoid signalling. Life Sci 78, 549-563.
17. den Boon FS, Chameau P, Schaafsma-Zhao Q, van Aken W, Bari M, Oddi S, Kruse CG, Maccarrone M, Wadman WJ & Werkman TR (2012). Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors. Proc Natl Acad Sci USA 109, 3534-3539.
18. Devane WA, Dysarz FA 3rd, Johnson MR, Melvin LS & Howlett AC (1988). Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34, 605-613.
19. Di Marzo V & Petrosino S (2007). Endocannabinoids and the regulation of their levels in health and disease. Curr Opin Lipidol 18, 129-140.
20. Fan N, Yang H, Zhang J & Chen C (2010). Reduced expression of glutamate receptors and phosphorylation of CREB are responsible for in vivo Δ9-THC exposure-impaired hippocampal synaptic plasticity. J Neurochem 112, 691-702.
21. 2 receptor: a new target for controlling neural cell survival? Trends Pharmacol Sci 28, 39-45.
22. 2A) receptor activity via ERK1/2 signaling. Synapse 67, 145-159.
23. A receptors. Br J Pharmacol 165, 951-964.
24. García-Gutiérrez MS, Ortega-Álvaro A, Busquets-García A, Pérez-Ortiz JM, Caltana L, Ricatti MJ, Brusco A, Maldonado R & Manzanares J (2013). Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors. Neuropharmacology 73, 388-396.
25. Giovannini MG (2006). The role of the extracellular signal-regulated kinase pathway in memory encoding. Rev Neurosci 17, 619-634.
26. Gong JP, Onaivi ES, Ishiguro H, Liu QR, Tagliaferro PA, Brusco A & Uhl GR (2006). Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 1071, 10-23.
27. 2) selective agonists. J Med Chem 56, 8224-8256.
28. 9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation. Learn Mem 14, 63-74.
29. Ishiguro H, Horiuchi Y, Ishikawa M, Koga M, Imai K, Suzuki Y, Morikawa M, Inada T, Watanabe Y, Takahashi M, Someya T, Ujike H, Iwata N, Ozaki N, Onaivi ES, Kunugi H, Sasaki T, Itokawa M, Arai M, Niizato K, Iritani S, Naka I, Ohashi J, Kakita A, Takahashi H, Nawa H & Arinami T (2010). Brain cannabinoid CB2 receptor in schizophrenia. Biol Psychiatry 67, 974-982.
30. 2 receptor-mediated anti-nociception in models of acute and chronic pain. Mol Neurobiol 36, 26-35.
31. Jones CA, Watson DJ & Fone KC (2011). Animal models of schizophrenia. Br J Pharmacol 164, 1162-1194.
32. Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M & Watanabe M (2009). Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 89, 309-380.
33. Katona I & Freund TF (2012). Multiple functions of endocannabinoid signaling in the brain. Annu Rev Neurosci 35, 529-558.
34. Katona I, Sperlágh B, Sík A, Käfalvi A, Vizi ES, Mackie K & Freund TF (1999). Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19, 4544-4558.
35. Maletic-Savatic M, Malinow R & Svoboda K (1999). Rapid dendritic morphogenesis in CA1 hippocampal dendrites induced by synaptic activity. Science 283, 1923-1927.
36. Marsicano G & Lutz B (1999). Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci 11, 4213-4225.
37. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC & Bonner TI (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
38. Mazzucchelli C, Vantaggiato C, Ciamei A, Fasano S, Pakhotin P, Krezel W, Welzl H, Wolfer DP, Pagès G, Valverde O, Marowsky A, Porrazzo A, Orban PC, Maldonado R, Ehrengruber MU, Cestari V, Lipp HP, Chapman PF, Pouysségur J & Brambilla R (2002). Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. Neuron 34, 807-820.
39. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, Pertwee RG, Griffin G, Bayewitch M, Barg J & Vogel Z (1995). Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50, 83-90.
40. Minocci D, Massei J, Martino A, Milianti M, Piz L, Di Bello D, Sbrana A, Martinotti E, Rossi AM & Nieri P (2011). Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor. J Affect Disord 134, 427-430.
41. Morgan NH, Stanford IM & Woodhall GL (2009). Functional CB2 type cannabinoid receptors at CNS synapses. Neuropharmacology 57, 356-368.
42. Munro S, Thomas KL & Abu-Shaar M (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61-65.
43. Nägerl UV, Eberhorn N, Cambridge SB & Bonhoeffer T (2004). Bidirectional activity-dependent morphological plasticity in hippocampal neurons. Neuron 44, 759-767.
44. 2 receptor-mediated regulation of impulsive-like behaviour in DBA/2 mice. Br J Pharmacol 165, 260-273.
45. Onaivi ES, Ishiguro H, Gong JP, Patel S, Meozzi PA, Myers L, Perchuk A, Mora Z, Tagliaferro PA, Gardner E, Brusco A, Akinshola BE, Hope B, Lujilde J, Inada T, Iwasaki S, Macharia D, Teasenfitz L, Arinami T & Uhl GR (2008). Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects. PLoS One 3, e1640.
46. Onaivi ES, Ishiguro H, Gong JP, Patel S, Perchuk A, Meozzi PA, Myers L, Mora Z, Tagliaferro P, Gardner E, Brusco A, Akinshola BE, Liu QR, Hope B, Iwasaki S, Arinami T, Teasenfitz L & Uhl GR (2006). Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann NY Acad Sci 1074, 514-536.
47. Onaivi ES, Ishiguro H, Gu S & Liu QR (2012). CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity. J Psychopharmacol 26, 92-103.
48. 2 cannabinoid receptor induces schizophrenia-related behaviors in mice. Neuropsychopharmacology 36, 1489-1504.
49. 2 cannabinoid receptor in the regulation of central immune responses during neuropathic pain. J Neurosci 28, 12125-12135.
50. Rodriguez A, Ehlenberger DB, Dickstein DL, Hof PR & Wearne SL (2008). Automated three-dimensional detection and shape classification of dendritic spines from fluorescence microscopy images. PLoS One 3, e1997.
51. Romero-Zerbo SY, Garcia-Gutierrez MS, Suárez J, Rivera P, Ruz-Maldonado I, Vida M, Rodriguez de Fonseca F, Manzanares J & Bermúdez-Silva FJ (2012). Overexpression of cannabinoid CB2 receptor in the brain induces hyperglycaemia and a lean phenotype in adult mice. J Neuroendocrinol 24, 1106-1119.
52. Rosenmund C & Stevens CF (1996). Definition of the readily releasable pool of vesicles at hippocampal synapses. Neuron 16, 1197-1207.
53. Satoh Y, Endo S, Ikeda T, Yamada K, Ito M, Kuroki M, Hiramoto T, Imamura O, Kobayashi Y, Watanabe Y, Itohara S & Takishima K (2007). Extracellular signal-regulated kinase 2 (ERK2) knockdown mice show deficits in long-term memory; ERK2 has a specific function in learning and memory. J Neurosci 27, 10765-10776.
54. Satoh Y, Endo S, Nakata T, Kobayashi Y, Yamada K, Ikeda T, Takeuchi A, Hiramoto T, Watanabe Y & Kazama T (2011). ERK2 contributes to the control of social behaviors in mice. J Neurosci 31, 11953-11967.
55. Schneggenburger R, Meyer AC & Neher E (1999). Released fraction and total size of a pool of immediately available transmitter quanta at a calyx synapse. Neuron 23, 399-409.
56. Segal M (2005). Dendritic spines and long-term plasticity. Nat Rev Neurosci 6, 277-284.
57. Selcher JC, Nekrasova T, Paylor R, Landreth GE & Sweatt JD (2001). Mice lacking the ERK1 isoform of MAP kinase are unimpaired in emotional learning. Learn Mem 8, 11-19.
58. Showalter VM, Compton DR, Martin BR & Abood ME (1996). Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J Pharmacol Exp Ther 278, 989-999.
59. Stevens CF & Williams JH (2007). Discharge of the readily releasable pool with action potentials at hippocampal synapses. J Neurophysiol 98, 3221-3229.
60. Sugiura T, Kondo S, Kishimoto S, Miyashita T, Nakane S, Kodaka T, Suhara Y, Takayama H & Waku K (2000). Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J Biol Chem 275, 605-612.
61. Svíženská I, Dubový P & Šulcová A (2008). Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures - a short review. Pharmacol Biochem Behav 90, 501-511.
62. Sweatt JD ( 2004). Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol 14, 311-317.
63. Tagliaferro P, Javier Ramos A, Onaivi ES, Evrard SG, Lujilde J & Brusco A (2006). Neuronal cytoskeleton and synaptic densities are altered after a chronic treatment with the cannabinoid receptor agonist WIN 55, 212-2. Brain Res 1085, 163-176.
64. Thiagarajan TC, Lindskog M, Malgaroli A & Tsien RW (2007). LTP and adaptation to inactivity: overlapping mechanisms and implications for metaplasticity. Neuropharmacology 52, 156-175.
65. Thiels E & Klann E (2001). Extracellular signal-regulated kinase, synaptic plasticity, and memory. Rev Neurosci 12, 327-345.
66. Tong D, He S, Wang L, Jin L, Si P & Cheng X (2013). Association of single-nucleotide polymorphisms in the cannabinoid receptor 2 gene with schizophrenia in the Han Chinese population. J Mol Neurosci 51, 454-460.
67. 2 receptors. Science 310, 329-332.
68. Wang G, Cheng Y, Gong M, Liang B, Zhang M, Chen Y, Zhang C, Yuan X & Xu J (2013). Systematic correlation between spine plasticity and the anxiety/depression-like phenotype induced by corticosterone in mice. Neuroreport 24, 682-687.
69. Wilson RI, Kunos G & Nicoll RA (2001). Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron 31, 453-462.
70. Zheng C, Chen L, Chen X, He X, Yang J, Shi Y & Zhou N (2013). The second intracellular loop of the human cannabinoid CB2 receptor governs G protein coupling in coordination with the carboxyl terminal domain. PLoS One 8, e63262.
71. Zhou Q, Homma KJ & Poo MM (2004). Shrinkage of dendritic spines associated with long-term depression of hippocampal synapses. Neuron 44, 749-757.